Boosting Immunity in Relation to HIV with LIV Capsules
Watch this video where Boosting Immunity in Relation to HIV with LIV Capsules is explained.
Human Immunodeficiency Virus (HIV)
- Once a patient is infected with HIV, the virus penetrates into their white blood cells known as CD4s which are responsible in boosting the immune system.
- The virus then destroys those CD4 cells and moves on to destroy other CD4 cells.
- The HIV virus hides in the white blood cells making them difficult to detect and kill.
HIV patients do not die of HIV. When their immune system is weakened, they become susceptible to other opportunistic diseases caused by bacteria, fungi and other viruses.
- Nowadays, HIV patients are treated with antiretroviral drugs that help reduce the viral load.
- The antiretroviral drugs have some limitations though:
- They do not help rapidly repair their immune system of the patient by restoring their CD4 cells.
- They may cause various side effects in users such as rashes, hives nausea and fevers.
Research results have shown that the CD4 most depleted by the HIV virus is Th17 cells.
Studies also revealed that increasing Th17 levels can help control the spread of HIV
Increasing Th17 Cells in the Gut May Improve the Control of HIV Growth
June 11, 2012
Immune cells may improve the control of HIV growthKristina Abel, PhD
A new study from a team of microbiologists and immunologists suggests that treatment aimed at increasing Th17 cells in the gut may improve the control of HIV growth by promoting an environment in which T cells having more anti-viral capabilities are produced.
Chapel Hill, North Carolina – The findings of a new study in monkeys may help clarify why some people infected with HIV are better able to control the virus. They also may pinpoint a target for treatment during early HIV infection aimed at increasing the supply of certain immune cells in the gut, which the study shows could be an important factor in limiting HIV growth in cells throughout the body.
Th17 as a vaccine
UCSF Researchers Identify A Potential New HIV Vaccine/Therapy Target
By Jeff Sheehy on May 30, 2012
After being infected with simian immunodeficiency virus (SIV) in a laboratory study, rhesus macaques that had more of a certain type of immune cell in their gut than others had much lower levels of the virus in their blood, and for six months after infection were better able to control the virus.
SIV is a retrovirus that infects primates. Strains of SIV that crossed over to humans resulted in the evolution of HIV. In rhesus macaques, SIV causes simian AIDS (though in many primates it is harmless) and studying the virus in these animals offers crucial insights into how HIV acts in humans, the researchers said.
Boosting Immunity in Relation to HIV
APCO scientists came up with LIV capsules which are formulated from plant extracts and have been proven to stimulate Th17, Th1 and Th9 by 5, 2 and 2 folds respectively.
All the stimulated Th cells increase the activities of natural killer cells and cytotoxic T-cells that eliminate HIV
Results of the LIV efficiency test carried out at the Biomedical Technology Research Centre, Chiang Mai University
Healthy volunteers were given 4 LIV capsules a day for 15 days. This resulted in:
- a doubling of their Th1 and Th9 activity.
- a five times increase in their Th17 activity.
Scientific Study of The Effects of LIV, 4 Capsules a day for 15 days
Previous research findings
GM-1 in the mangosteen extract used in the LIV capsule inhibits reverse transcriptase and protease enzymes which are essential in the virus replication process.
Planta Med. 1996. Aug 62(4):381-2
Test Results of Tests on the Use of LIV Capsules by HIV-Affected Persons
A research study conducted by Prof. Dr. Watchara Kasinrerk (APCO Chair Professor) and Nopporn Pattanapornpun, MD. (Director of Mae-On hospital in Chiang Mai), showed that the CD4 cell count in HIV patients increased after taking 4 LIV capsules daily for 6-9 months.
APCO has given LIV capsules to HIV-infected volunteers in Chiang Mai who have been taking antiretroviral drugs for two years with the following results:
- Their quality of life has improved significantly.
- Those suffering from opportunistic infection such as viral infection, tuberculosis and pneumonia saw their symptoms remedied.
Test Results of Tests on the Use of LIV Capsules by HIV-Affected Patients
At Baan Gerda Children’s Rights Foundation, APCO has given LIV capsules to HIV-infected children who were taking antiretroviral drugs and suffering from opportunistic diseases.
- After taking 4 LIV capsules a day for 12 months, the opportunistic diseases symptoms were remedied and their CD4 count increased by an average of 67.34%.
- A group of children who were already taking antiretroviral drugs but whose CD4 count had not increased for the previous 6 months had an average increase of 32.45% in their CD4 count after taking 9 LIV capsules a day for 3 months.
Benefits of Taking LIV Capsules
- LIV helps rapidly increase the person’s CD4 count.
- LIV helps eliminate the HIV virus by increasing Th1, Th9 and Th17 activity.
- LIV helps remedy opportunistic infections by boosting the body’s immune system.
- LIV helps reduce the side effects caused by antiretroviral drugs.
- LIV helps improve the quality of life of HIV affected persons, enabling them to live normal lives.
Options for HIV affected persons to increase their CD4 Count:
- Taking Interleukin 2 injections to increase their lymphocytes and CD4 count. This drug is very costly, over 30 times the cost of LIV capsules and has many side effects.
- Taking 6-9 LIV capsules a day similarly increases lymphocytes and CD4 count, as well as improves overall health by balancing the immune system.